TL;DR
Turn quiet afternoons into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
A review in the Journal of the Endocrine Society reports possible links between polyendocrine metabolic ovarian syndrome (PMOS), formerly called PCOS, and changes in memory, thinking and brain health associated with dementia. The authors say metabolic conditions such as insulin resistance and obesity may help explain the association; the review does not establish that PMOS causes Alzheimer’s disease or dementia.
A review of existing research has identified possible links between polyendocrine metabolic ovarian syndrome (PMOS) and changes in memory, thinking and brain health associated with Alzheimer’s disease and dementia. Published in the Journal of the Endocrine Society, the review does not show that PMOS causes dementia; its authors say the association may be tied chiefly to related metabolic conditions, including insulin resistance and obesity.
The researchers conducted a PubMed search covering studies from the database’s inception through October 2025. They reviewed existing evidence on PMOS and Alzheimer’s disease and related dementias, rather than running a new clinical trial or following a new group of patients over time. The paper, by Mina Amiri and colleagues, is titled “Potential links between PCOS/PMOS and Alzheimer disease and related dementias.”
As summarized in the report, the authors found evidence that people with PMOS may experience mild but reproducible difficulties in executive function and memory, alongside structural and functional changes in the brain. The review interprets these findings as possible indicators of greater vulnerability to dementia-related changes. They are not proof that an individual with PMOS will develop Alzheimer’s disease or another dementia.
The authors also point to obesity and metabolic disorders that commonly accompany PMOS as possible explanations for the observed relationship. The evidence reviewed cannot establish whether PMOS has an independent effect on dementia risk, or determine how much any association is accounted for by related health conditions. The work was funded by the Foundation for Research and Education Excellence.
Metabolic Health May Shape the Link
The review brings attention to a possible connection between a condition affecting reproductive and metabolic health and later brain health. PMOS is estimated to affect 10% to 15% of women worldwide, according to the source report, and is associated with health issues that include diabetes and heart disease. If metabolic factors help connect PMOS with dementia-related changes, understanding that relationship could help researchers identify shared biological pathways and guide future studies.
For readers, the distinction between an association and a cause is central. The review does not establish that PMOS independently raises a person’s chance of Alzheimer’s disease, nor does it provide a personal risk estimate or show that treating PMOS prevents dementia. Its value is in gathering evidence and identifying questions that need stronger study, not in changing clinical guidance on its own.
hormonal balance supplements for women
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
From PCOS to PMOS Research
The review uses the term polyendocrine metabolic ovarian syndrome, or PMOS, for a condition formerly known as polycystic ovary syndrome (PCOS). The source report describes PMOS as having wide-ranging health associations, including diabetes, cardiovascular disease, stroke, depression, anxiety, infertility and endometrial cancer. It can have effects across a person’s life, and may also affect males in different ways.
The new paper is a review of published evidence, not a study that directly measures dementia incidence in a newly recruited population. Its findings therefore depend on the quality and reach of the research already available. The authors’ search included material available through October 2025; the review highlights gaps in knowledge and proposes further research into how PMOS, metabolic health and brain changes may relate.
“Current evidence suggests that any association between PMOS and Alzheimer’s disease and dementia is likely mediated by metabolic comorbidities, particularly insulin resistance and obesity, rather than an independent effect of PMOS itself.”
— Ricardo Azziz, M.D., M.P.H., M.B.A., study co-author at the University of Alabama at Birmingham
metabolic health monitoring devices
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Cause and Risk Remain Unresolved
The review does not establish causation, quantify dementia risk among people with PMOS, or show whether the relationship differs by age, severity of symptoms or other health factors. It also does not determine whether PMOS itself contributes to brain changes independently of insulin resistance, obesity or other conditions. The available source material provides no specific risk percentage or comparison with people without PMOS.
Because this is a review of existing studies, the strength of its conclusions is limited by what those studies measured and how they were designed. The supplied report does not detail the number of studies included or provide a pooled estimate of risk. Further research is needed before the possible association can be translated into reliable individual risk predictions or screening recommendations.
brain health supplements for women
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Studies Must Test the Pathways
The authors identify research gaps and call for further work on the relationship between PMOS, metabolic conditions and brain health. Future studies could help distinguish the contribution of PMOS itself from that of related factors such as insulin resistance and obesity, and examine how changes in memory and brain structure relate to diagnoses of dementia over time.
No follow-up study, clinical guidance change or new treatment was announced in the source report. For now, the review is a synthesis of existing evidence and a basis for further investigation. People making decisions about their health should discuss individual concerns with a qualified health professional; this review is not medical advice.
As an affiliate, we earn on qualifying purchases.
Key Questions
What is PMOS?
PMOS is the term used in the review for a condition formerly known as polycystic ovary syndrome (PCOS). The source report says it is associated with reproductive, hormonal and metabolic health issues.
Does the review prove that PMOS causes Alzheimer’s disease?
No. It reviews existing research and reports a possible association. The authors say related metabolic conditions, including insulin resistance and obesity, may help explain the link; the review does not establish cause and effect.
What brain-related findings did the review discuss?
The report describes evidence of mild, reproducible difficulties in memory and executive function, as well as structural and functional brain changes in people with PMOS. These findings do not show that those individuals will develop dementia.
How much higher is dementia risk for people with PMOS?
The supplied report does not give a specific risk estimate or a numerical comparison with people without PMOS. It says the evidence suggests a possible link and identifies gaps that require further research.
Does the review recommend a new screening test or treatment?
No new screening test or treatment recommendation is reported. The paper calls for more research into the relationship between PMOS, metabolic health and brain changes; health decisions should be discussed with a qualified professional.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
